Health In Tech, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HIT research report →
Range $3 – $3
Price Chart
About the company
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs.
- CEO
- Sanjay Kumar Shrestha
- IPO
- 2024
- Employees
- 89
- HQ
- Stuart, FL, US
Get TickerSpark's AI analysis on HIT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $20.51M
- P/E
- -1.74
- PEG
- 0.01
- P/S
- 0.56
- P/B
- 1.59
- EV/EBITDA
- -1.05
- Div Yield
- 0.00%
- Gross Margin
- 51.42%
- Op Margin
- -45.79%
- Net Margin
- -37.09%
- ROE
- -64.51%
- ROIC
- -55.10%
Latest fiscal year · YoY change
- Revenue
- $33.33M+71.0%
- Gross Profit
- $20.94M+35.6%
- Op Income
- $1.53M
- Net Income
- $1.28M+90.7%
- EPS
- $0.02+62.6%
- OCF Growth
- +44.0%
- FCF Growth
- -104.4%
- 52W High
- $2.10
- 52W Low
- $0.30
- 50D MA
- $0.67
- 200D MA
- $1.10
- Beta
- 3.02
- RSI (14)
- 34
- Avg Volume
- 176.03K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
HealthInTech reported lower third-quarter revenue and earnings but said the business is entering 2027 with a larger pipeline, improved cash burn, and several new products nearing commercialization.· November 12, 2026
- Q3 revenue was $6.6 million, down from $8.5 million a year ago; 9M revenue was $23.4 million vs. $25.8 million last year.
- Gross margin fell to 46.5% from 60.6% in Q3 as the company added plan administration services and absorbed more direct service costs.
- A $5.3 million credit-loss provision and a carrier transition weighed on results, but management said the carrier issue is now substantially behind them.
- The company ended the quarter with $10.1 million of cash and said operating cash burn improved each quarter this year, to negative $1 million in Q3.
- Management emphasized a new CEO-led push to improve conversion, execution discipline, and commercialization of HitRix, HitChain, and the 3-year rate stabilization program.
Total revenue for the third quarter was $6.6 million, compared with $8.5 million a year ago. For the first 9 months of 2026, revenue was $23.4 million versus $25.8 million last year. Gross margin was 46.5% in Q3, down from 60.6%, and 49.1% for the first 9 months versus 65.1% a year ago. Adjusted EBITDA was negative $3.9 million in Q3 versus positive $1 million last year, and negative $6.6 million for 9M versus positive $3.8 million. Net loss was $7.1 million, or $0.11 per basic and diluted share, versus net income of $0.5 million, or $0.01 per diluted share, in the prior-year quarter. Full-year 2026 revenue outlook was updated to approximately $30 million. Management said contracted revenue for the first 9 months totaled $32.7 million, with $24.4 million already recognized, $6.1 million scheduled for Q4, and $2.2 million flowing into 2027; pipeline revenue as of October 30 was $1.56 billion (as stated on the call), with management saying 3% to 7% conversion on the 3-month policy window could generate $9.3 million to $10.7 million of revenue. Cash and cash equivalents were $10.1 million at quarter-end, and operating cash burn improved from negative $3.3 million in Q1 to negative $2.9 million in Q2 to negative $1 million in Q3.
Tim Johnson framed the leadership change as a way to split responsibilities between long-term innovation and near-term execution, saying his focus remains on strategy and product development while Sanjay Shrestha runs day-to-day operations. He said the company needs a stronger emphasis on commercial execution, operational scalability, and strategic growth opportunities, including acquisitions and partnerships. His tone was supportive of the transition and optimistic about the platform, but he repeatedly stressed that the company must turn its technology and relationships into measurable commercial results.
Julia Qian focused on the gap between forward-looking commercial activity and reported GAAP results. She said contracted revenue for the first 9 months was $32.7 million, with $24.4 million recognized so far, and highlighted that cash improved to $10.1 million at quarter-end from $7.7 million at year-end 2025. She attributed the margin decline to the new self-funded plan administration model, said gross margin should stay in the 45% to 50% range in coming quarters, and explained the $5.3 million credit-loss provision as a combination of receivables aging, legacy surplus administration receivables, and a loan write-off tied to a prior overseas arrangement. She also said total operating cash burn improved 68% from Q1 to Q3 and that 2027 should be a different year as new products are commercialized.
Analysts pressed management on why revenue declined year over year, and Julia said a new carrier onboarding caused temporary delays and extra manual work, slowing conversion from coding to contractual revenue. Questions about the $5.3 million credit-loss provision led Julia to break it into receivables, surplus administration receivables, and loan write-offs, while noting the company is shifting focus to the U.S. market. On the 3-year rate stabilization product, management said the insurance piece is substantially complete but the capital-market financing is still being finalized, with the first launch targeted by year-end if possible. On HitRix and pipeline conversion, Sanjay said the company must improve broker execution and conversion rates, but would not commit to a specific target yet; he also said HitRix could start contributing in 2027, while HitChain is more likely a second-half 2027 opportunity.
Management said the company has built a meaningful pipeline, with 984 distribution partners and a large amount of potential business in the renewal cycle. They also pointed to three new initiatives that could expand the addressable market and contribute more meaningfully in 2027: the 3-year rate stabilization program, HitRix, and HitChain. Cash and operating cash burn both improved during the year, and management said the carrier transition is now substantially behind them.
The quarter showed weaker reported revenue, lower margins, and negative adjusted EBITDA, and management openly said they are not satisfied with current revenue performance. A large credit-loss provision also raised concerns about receivables quality and legacy arrangements, while the company acknowledged that product commercialization and carrier onboarding took longer than expected. Management also said it is still reviewing 2027 priorities, so the timing and scale of future growth initiatives remain uncertain.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 21.7%
- Shares Outstanding
- 53.60M
- Float Shares
- 11.61M
of shares held by institutions
21 13F filers
Buy/sell ratio 1.20. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Whetstone Capital Advisors, LLC | 1.77M | ▲ 255.74K |
| Mink Brook Asset Management LLC | 1.24M | ▲ 106.68K |
| Vanguard Capital Management LLC | 695.48K | ▲ 127.01K |
| Vanguard Group Inc | 640.04K | ▲ 284.11K |
| Blackrock, Inc. | 346.71K | ▼ 2.88K |
| Heights Capital Management, Inc | 253.19K | ▼ 97.08K |
| Geode Capital Management, LLC | 235.64K | ▲ 14.99K |
| Citadel Advisors LLC | 159.16K | ▼ 17.75K |
| Vanguard Fiduciary Trust Co | 130.48K | 0 |
| State Street Corp | 86.40K | ▲ 23.50K |
| Northern Trust Corp | 57.66K | 0 |
| Hrt Financial LP | 27.94K | ▲ 27.94K |
Held by 22 ETFs
Biggest fund positions in HIT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 26 | Qian LinLin | other | 78,842 |
| Nov 13, 26 | Johnson Tim Donald | other | 190,323 |
| Nov 13, 26 | Hasan Zain Syed | other | 10,740 |
| Nov 10, 26 | Shrestha Sanjay K | other | 500,000 |
| Nov 10, 26 | Shrestha Sanjay K | other | 500,000 |
| Nov 10, 26 | Shrestha Sanjay K | other | 1,500,000 |
| Nov 10, 26 | Qian LinLin | other | 200,000 |
| Nov 10, 26 | Qian LinLin | other | 200,000 |
| Nov 10, 26 | Qian LinLin | other | 600,000 |
| Nov 10, 26 | Qian LinLin | other | 600,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HIT coverage
Recent articles, reports, and earnings notes.
No research on HIT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HIT report →Health In Tech Expands National Distribution Through TPA Serving More Than 100,000 Employees
prnewswire.com · Nov 19
Health In Tech Appoints Tim Cortes as Independent Director, Chair of the Compensation Committee
prnewswire.com · Nov 18
Health In Tech Appoints Wall Street Research and Capital Markets Veteran Christina R. Valauri to Board of Directors
prnewswire.com · Nov 17
Health In Tech, Inc. (HIT) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 13
Health In Tech Reports Third Quarter 2026 Financial Results
prnewswire.com · Nov 12
Health In Tech, Inc. (HIT) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com · Nov 10
Critical Analysis: Schrodinger (NASDAQ:SDGR) versus Health In Tech (NASDAQ:HIT)
defenseworld.net · Nov 9
Health In Tech to Announce Third Quarter 2026 Financial Results on November 12, 2026
prnewswire.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.